Swiss National Bank’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.14M Sell
216,200
-1,000
-0.5% -$33K ﹤0.01% 1093
2025
Q1
$8.73M Sell
217,200
-2,600
-1% -$104K 0.01% 964
2024
Q4
$10.3M Buy
219,800
+4,300
+2% +$202K 0.01% 930
2024
Q3
$11.4M Buy
215,500
+20,000
+10% +$1.06M 0.01% 875
2024
Q2
$10.6M Buy
195,500
+21,300
+12% +$1.15M 0.01% 877
2024
Q1
$12.2M Buy
174,200
+3,900
+2% +$273K 0.01% 827
2023
Q4
$14.2M Sell
170,300
-29,500
-15% -$2.46M 0.01% 729
2023
Q3
$5.89M Buy
199,800
+2,100
+1% +$61.9K ﹤0.01% 1184
2023
Q2
$6.45M Buy
197,700
+3,700
+2% +$121K ﹤0.01% 1153
2023
Q1
$6.83M Sell
194,000
-22,000
-10% -$774K ﹤0.01% 1078
2022
Q4
$9.9M Buy
216,000
+23,000
+12% +$1.05M 0.01% 919
2022
Q3
$9.35M Buy
193,000
+5,300
+3% +$257K 0.01% 914
2022
Q2
$7.38M Buy
187,700
+9,200
+5% +$361K 0.01% 1080
2022
Q1
$6.57M Buy
178,500
+13,200
+8% +$486K ﹤0.01% 1275
2021
Q4
$7.53M Buy
165,300
+3,200
+2% +$146K ﹤0.01% 1190
2021
Q3
$5.79M Buy
162,100
+37,300
+30% +$1.33M ﹤0.01% 1357
2021
Q2
$2.47M Sell
124,800
-20,700
-14% -$410K ﹤0.01% 1963
2021
Q1
$3.38M Buy
145,500
+2,000
+1% +$46.5K ﹤0.01% 1690
2020
Q4
$2.98M Buy
143,500
+7,300
+5% +$152K ﹤0.01% 1680
2020
Q3
$2.95M Buy
136,200
+24,100
+21% +$522K ﹤0.01% 1512
2020
Q2
$2.64M Buy
112,100
+14,700
+15% +$346K ﹤0.01% 1548
2020
Q1
$1.15M Buy
97,400
+2,000
+2% +$23.6K ﹤0.01% 1746
2019
Q4
$1.01M Buy
95,400
+3,300
+4% +$35K ﹤0.01% 2133
2019
Q3
$1.05M Buy
92,100
+5,500
+6% +$62.6K ﹤0.01% 2036
2019
Q2
$974K Buy
86,600
+4,500
+5% +$50.6K ﹤0.01% 2127
2019
Q1
$664K Hold
82,100
﹤0.01% 2280
2018
Q4
$519K Sell
82,100
-3,300
-4% -$20.9K ﹤0.01% 2343
2018
Q3
$841K Hold
85,400
﹤0.01% 2237
2018
Q2
$709K Buy
85,400
+11,300
+15% +$93.8K ﹤0.01% 2339
2018
Q1
$534K Buy
74,100
+8,900
+14% +$64.1K ﹤0.01% 2355
2017
Q4
$531K Hold
65,200
﹤0.01% 2392
2017
Q3
$945K Buy
65,200
+7,600
+13% +$110K ﹤0.01% 2094
2017
Q2
$697K Buy
+57,600
New +$697K ﹤0.01% 2277